Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Federal Bills Protecting Contraceptive Access Pending

This article was originally published in The Tan Sheet

Executive Summary

Two bills in the House and Senate are aimed at providing women with unimpeded access to oral contraception, including the "morning after" pill

You may also be interested in...



EC Scripts Could Be Provided With List of Willing Dispensers – Rep. Manzullo

The debate over whether pharmacists should be required to dispense emergency contraception could be defused if women were given a list of pharmacists who willingly dispense the drug along with their prescriptions, House Small Business Committee Chairman Don Manzullo (R-Ill.) suggested in a July 25 statement

EC Scripts Could Be Provided With List of Willing Dispensers – Rep. Manzullo

The debate over whether pharmacists should be required to dispense emergency contraception could be defused if women were given a list of pharmacists who willingly dispense the drug along with their prescriptions, House Small Business Committee Chairman Don Manzullo (R-Ill.) suggested in a July 25 statement

EC Scripts Could Be Provided With List of Willing Dispensers – Rep. Manzullo

The debate over whether pharmacists should be required to dispense emergency contraception could be defused if women were given a list of pharmacists who willingly dispense the drug along with their prescriptions, House Small Business Committee Chairman Don Manzullo (R-Ill.) suggested in a July 25 statement

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS098114

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel